Renovia names new president and CEO; completes enrollment for randomized control trial Women-led team achieves key milestone ahead of schedule Boston, Mass.—January 19, 2021—Renovia Inc. (“Renovia”), a women-led company that develops digital therapeutics for female...

Renovia presents at Piper Sandler Healthcare Conference Medical Technology Disruptors Panel includes Renovia’s leva® Digital Therapeutic, a novel approach for an underreported disorder affecting 20 million women in the U.S. Boston, Mass.—December 1, 2020—Renovia Inc....

Boston, MA – November 25, 2019 – Renovia Inc. (“Renovia”), a company dedicated to discovering and delivering first-line digital therapeutic and diagnostic device and app technologies for women with pelvic floor disorders, today announced U.S. Food and Drug Administration (FDA) 510(k) clearance for the next-generation leva® Pelvic Digital Therapeutic for the strengthening of pelvic floor muscles and the treatment of stress, mixed and mild to moderate urgency urinary incontinence (UI) in women.

Study Demonstrates Improvements in Objective Pelvic Floor Muscle Measures, Patient-Reported Urinary Incontinence Severity and Condition-Specific Quality of Life, with Results Evident after 1 Week of Use

Boston, MA – March 28, 2019 – Renovia Inc. (“Renovia”), a company dedicated to discovering and delivering first-line digital therapeutic and diagnostic devices for women with pelvic floor disorders, today announced that it has received a nomination for MedTech Company...

Boston, MA – March 14, 2019– Renovia Inc. (“Renovia”), a company dedicated to discovering and delivering first-line digital therapeutic and diagnostic devices for women with pelvic floor disorders, today announced Jim O’Connor has been promoted to General Counsel...

Boston, MA – January 9, 2019– Renovia Inc. ("Renovia"), a company dedicated to discovering and delivering first-line digital therapeutic and diagnostic devices for women with pelvic floor disorders, today announced John A. Fallon, M.D. has joined its Board of...

Six-Center Study Will Compare Renovia’s Pelvic Digital Therapeutic System to Standard of Care Pelvic Floor Muscle Exercises in Home-based Treatment of Stress-dominant Urinary Incontinence Boston, MA – November 12, 2018 – Renovia Inc. (“Renovia”), a company dedicated...

Boston, MA – October 31, 2018– Renovia Inc. (“Renovia”), a company dedicated to discovering and delivering first-line digital therapeutic and diagnostic devices for women with pelvic floor disorders, today announced Tara Butler, M.D. has joined its Board of Directors....

Boston, MA – Sept 12, 2018– Renovia Inc. (“Renovia”), a company dedicated to discovering and delivering first-line digital therapeutic and diagnostic devices for women with pelvic floor disorders, today announced Dan Levangie has joined its Board of Directors. "Dan...

Renovia is Developing a Product Pipeline to Better Diagnose and Treat Women Affected by Pelvic Floor Disorders, including Urinary Incontinence Boston, MA – August 28, 2018 – Renovia Inc. ("Renovia"), a company dedicated to discovering and delivering first-line digital...

Financing Will Accelerate Clinical Research, Development and New Digital Therapeutic Device Launches Targeted at Pelvic Floor Disorders Boston, MA – August 21, 2018 – Renovia Inc. ("Renovia"), a company dedicated to discovering and delivering first-line digital...

Boston, MA- February 25th, 2018- Renovia, a company dedicated to discovering and delivering innovative medical solutions and technology combined with digital health to help individuals suffering from pelvic floor disorders, announced the appointment of Jim O’Connor as...

Boston, MA – December 13th, 2017 Renovia, a company dedicated to discovering and delivering innovative medical solutions and technology combined with digital health to help individuals suffering from pelvic floor disorders, announced the appointment of Samantha...